Photobiology, Circadian Light Science & Ophthalmic Lens IP
Acieon Labs is the research and intellectual property division of Sleepaxa Private Limited. It studies how biologically relevant wavelengths interact with retinal light-signalling pathways, including melanopsin and intrinsically photosensitive retinal ganglion cells, to guide wavelength-selective ophthalmic lens technologies.
Acieon Labs is a photobiology research division based in India. It develops and holds the intellectual property behind wavelength-selective ophthalmic lenses. Its work characterises how specific wavelengths of light drive melanopsin phototransduction in intrinsically photosensitive retinal ganglion cells, and how selective spectral filtration can preserve beneficial daytime light while attenuating the evening wavelengths that suppress melatonin and delay circadian phase.
Last updated: July 2026
Acieon Labs is a photobiology research and intellectual property division. We translate non-visual photoreception biology into research-led optical filtration frameworks. Our work begins at the photon and ends at the suprachiasmatic nucleus. We characterise how specific wavelengths drive melanopsin phototransduction in intrinsically photosensitive retinal ganglion cells, and we engineer spectral filters that preserve beneficial daytime light while attenuating the evening wavelengths that suppress melatonin and delay circadian phase.
A clear separation of research and commerce
Acieon Labs
Research, IP, publications, patents, ethics, evidence, and clinical and scientific documentation.
Sleepaxa
Commercial eyewear products, consultation, customer support, order processing, and fulfilment.
Every photon works for the human eye.
Every photon that enters the eye carries spectral information. Some photons support vision and daytime alertness. Others, concentrated near the melanopic action spectrum, reach the circadian system at the wrong hour. The Acieon Labs principle is that filtration should be selective rather than blunt, so that every photon works for the human eye rather than against it.
Light is a spectrum, and the eye reads it
Across the 380 to 720 nm extended visible-to-near-red research window, the melanopsin response peaks near 480 nm. Acieon Labs studies how selective filtration shapes the light that reaches the circadian system.
380 to 720 nm. Extended visible-to-near-red research window
Six inventions. One granted national patent and five pending applications.
Each entry is filed with the Indian Patent Office and identified by its official application number.
An optical lens with dual-band selective light attenuation
GrantedA dual-band spectral filtration system that independently attenuates two tuned wavelength bands relevant to photophobic and circadian load while preserving photopic luminance and colour balance.
Patent Number 587746. Application 202521094370. All 10 claims allowed.
Nine research works deposited on Zenodo
An open research corpus, each work deposited with a resolving DOI.
Named authors with verifiable identifiers
One parent company, two divisions
Sleepaxa Private Limited
Parent company. DPIIT-recognised, CTRI-registered, Gujarat-registered parent company.
Sleepaxa
Product division. Photobiological eyewear product brand. Referenced only, never marketed on this site.
Product division: sleepaxa.inAcieon Labs
Research and intellectual property division of Sleepaxa Private Limited. Acieon publishes scientific, patent, and research documentation at acieon.com.
What is Acieon Labs?
Acieon Labs is the research and intellectual property division of Sleepaxa Private Limited, focused on photobiology, circadian light science, melanopsin and ipRGC signalling, wavelength-selective ophthalmic optics, and lens-related intellectual property.
Work with the research division
For research, intellectual property, or press enquiries, get in touch with Acieon Labs.